Close Menu

Mycophenolate mofetil

Mycophenolate Mofetil in Minimal Change Nephrosis

Issue: 
Pages: 
330–1
Synopsis: 
The use of mycophenolate mofetil in the treatment of steroid resistant minimal change disease has not been extensively studied, particularly in the African Caribbean population. This case highlights its use in steroid resistant nephrotic syndrome in an Afro-Caribbean adolescent.

INTRODUCTION

The use of mycophenolate mofetil in the treatment of steroid resistant minimal change disease has not been extensively studied, particularly in the African Caribbean population. This drug has fewer side effects than most immunosuppressants. On this basis, it may be preferred by both patient and physician. This case report highlights its use in a patient with minimal change nephrosis.

PDF Attachment: 
Journal Sections: 
Journal Authors: 
e-Published: 07 Oct, 2013
Subscribe to RSS - Mycophenolate mofetil
Top of Page